Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Diovan/Co-Diovan was produced by Novartis.

Pharma news in brief

Novartis says growth from older medicines such as heart drug Diovan and cancer pill Gleevec have fuelled a 13 per cent rise in third quarter profits.

R&D news in brief

Analysts believe Aliskiren is a potential blockbuster and could one day sit alongside Novartis' top-seller Diovan.

Sales growth and acquisitions boost Novartis profits

with operating margin increasing to 32 per cent on the back of strong sales of its best-selling hypertension treatment, Diovan.

Novartis delivers confident outlook despite Chiron costs

Chiron. Net income at the Swiss firm was below analysts' expectations, rising to $1.71bn, or 72 cents a share, on the back of solid sales of hypertension drug, Diovan and

US Galvus delay could impact Novartis Q3 FY07 results

Diovan and Glivec will continue to drive sales. Novartis' shares have dropped nine percent so far in 2007, which exceeds the fall in the European index, caused by setbacks at GlaxoSmithKline

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

How will COVID-19 affect uptake of vaccinations against other diseases?...
Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal
Even after the pandemic is long behind us, virtual collaboration will become mainstay in Pharma....
Living With Chronic Illness (Series one)...